These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 29493344)
21. Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation. Shakeri A; Sahebkar A J Neurosci Res; 2016 Feb; 94(2):111-3. PubMed ID: 26577706 [No Abstract] [Full Text] [Related]
22. Antioxidant and anti-inflammatory properties of curcumin. Menon VP; Sudheer AR Adv Exp Med Biol; 2007; 595():105-25. PubMed ID: 17569207 [TBL] [Abstract][Full Text] [Related]
23. Two in one against motor neuron degeneration: tackling oxidative stress and inflammation with a sulfasalazine derivative. Clement AM J Neurochem; 2012 Sep; 122(5):869-71. PubMed ID: 22730915 [No Abstract] [Full Text] [Related]
24. Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies. Brondino N; Re S; Boldrini A; Cuccomarino A; Lanati N; Barale F; Politi P ScientificWorldJournal; 2014; 2014():174282. PubMed ID: 24578620 [TBL] [Abstract][Full Text] [Related]
25. Cardiovascular protection by curcumin: molecular aspects. Kapakos G; Youreva V; Srivastava AK Indian J Biochem Biophys; 2012 Oct; 49(5):306-15. PubMed ID: 23259317 [TBL] [Abstract][Full Text] [Related]
27. Turmeric. Grant KL; Schneider CD Am J Health Syst Pharm; 2000 Jun; 57(12):1121-2. PubMed ID: 10911509 [No Abstract] [Full Text] [Related]
28. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model. Gugulothu D; Kulkarni A; Patravale V; Dandekar P J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287 [TBL] [Abstract][Full Text] [Related]
29. Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer. Kujundžić RN; Stepanić V; Milković L; Gašparović AČ; Tomljanović M; Trošelj KG Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857125 [TBL] [Abstract][Full Text] [Related]
30. Combined polymer-curcumin conjugate and ependymal progenitor/stem cell treatment enhances spinal cord injury functional recovery. Requejo-Aguilar R; Alastrue-Agudo A; Cases-Villar M; Lopez-Mocholi E; England R; Vicent MJ; Moreno-Manzano V Biomaterials; 2017 Jan; 113():18-30. PubMed ID: 27810639 [TBL] [Abstract][Full Text] [Related]
31. Selecting promising ALS therapies in clinical trials. Glass JD; Benatar M; Polak M Neurology; 2007 May; 68(18):1545-6; author reply 1546. PubMed ID: 17470765 [No Abstract] [Full Text] [Related]